These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 31326612

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pneumocystis jirovecii pneumonia is rare in renal transplant recipients receiving only one month of prophylaxis.
    Anand S, Samaniego M, Kaul DR.
    Transpl Infect Dis; 2011 Dec; 13(6):570-4. PubMed ID: 22093215
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pentamidine for Prophylaxis against Pneumocystis jirovecii Pneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy.
    Quinn M, Fannin JT, Sciasci J, Bragg A, Campbell PK, Carias D, Crews KR, Gregornik D, Jeha S, Maron G, Pauley JL, Swanson HD, Wolf J, Greene W.
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866879
    [Abstract] [Full Text] [Related]

  • 5. Pneumocystis jirovecii Pneumonia Prophylaxis with Intravenous Pentamidine in Adult Allogeneic Hematopoietic Stem Cell Transplant Patients.
    McCollam S, Lewis JS, Bubalo J, Diaz A.
    Antimicrob Agents Chemother; 2022 Nov 15; 66(11):e0083322. PubMed ID: 36214573
    [Abstract] [Full Text] [Related]

  • 6. Nocardia infection in lung transplant recipients.
    Husain S, McCurry K, Dauber J, Singh N, Kusne S.
    J Heart Lung Transplant; 2002 Mar 15; 21(3):354-9. PubMed ID: 11897524
    [Abstract] [Full Text] [Related]

  • 7. Nocardiosis in Immunocompromised Patients on Alternative Pneumocystis Prophylaxis.
    Puing AG, Epstein DJ, Banaei N, Subramanian AK, Liu AY.
    Emerg Infect Dis; 2021 Oct 15; 27(10):2734-2736. PubMed ID: 34545802
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Increased Incidence of Nocardial Infections in an Era of Atovaquone Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
    Molina A, Winston DJ, Pan D, Schiller GJ.
    Biol Blood Marrow Transplant; 2018 Aug 15; 24(8):1715-1720. PubMed ID: 29555315
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients.
    Zmarlicka M, Martin ST, Cardwell SM, Nailor MD.
    Prog Transplant; 2015 Sep 15; 25(3):210-6. PubMed ID: 26308779
    [Abstract] [Full Text] [Related]

  • 12. Dapsone safety in hematology patients: Pathways to optimizing Pneumocystis jirovecii pneumonia prophylaxis in hematology malignancy and transplant recipients.
    Urbancic KF, Pisasale D, Wight J, Trubiano JA.
    Transpl Infect Dis; 2018 Dec 15; 20(6):e12968. PubMed ID: 30030892
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of low-dose cotrimoxazole prophylaxis against Pneumocystis carinii pneumonia after renal and/or pancreas transplantation.
    Elinder CG, Andersson J, Bolinder G, Tydén G.
    Transpl Int; 1992 May 15; 5(2):81-4. PubMed ID: 1627244
    [Abstract] [Full Text] [Related]

  • 14. Combination of caspofungin and low-dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients.
    Tu GW, Ju MJ, Xu M, Rong RM, He YZ, Xue ZG, Zhu TY, Luo Z.
    Nephrology (Carlton); 2013 Nov 15; 18(11):736-42. PubMed ID: 24571744
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation.
    Prasad GVR, Beckley J, Mathur M, Gunasekaran M, Nash MM, Rapi L, Huang M, Zaltzman JS.
    BMC Infect Dis; 2019 Apr 05; 19(1):311. PubMed ID: 30953458
    [Abstract] [Full Text] [Related]

  • 17. Is cotrimoxazole prophylaxis against Pneumocystis jirovecii pneumonia needed in patients with systemic autoimmune rheumatic diseases requiring immunosuppressive therapies?
    Pereda CA, Nishishinya-Aquino MB, Brito-García N, Díaz Del Campo Fontecha P, Rua-Figueroa I.
    Rheumatol Int; 2021 Aug 05; 41(8):1419-1427. PubMed ID: 33656582
    [Abstract] [Full Text] [Related]

  • 18. Effective Pneumocystis jiroveci pneumonia prophylaxis with trimethoprim-sulfamethoxazole once a day twice a week.
    Bostrom BC.
    Pediatr Blood Cancer; 2009 Aug 05; 53(2):239. PubMed ID: 19422030
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.